Guardion Health Sciences, (GHSI) serves as a specialist health sciences corporation in the United States and its subsidiaries. The organization works in two divisions, medical food, and medical devices. Medical Foods provides Lumega-Z, balanced nutrition that refills and replaces the macular antioxidant pigment, and GlaucoCetin. This vision-specific medical food promotes and preserves the optic nerve cells’ mitochondrial activity, as well as enhancement in blood supply in the visually affected artery of glaucoma patients. While medical devices division offers VectorVision’swhich designs, produces, and provides standardized vision monitoring equipment and materials for clinical trials, real-world vision assessment, and commercial vision testing for eyepers.
In the recent session Company’s stock finished up 8.14% to $0.55. During the last 52-week, the stock’s best price was $0.74, while the lowest price recorded was $0.1650. GHSI’s current Market capitalization is 48.58M,and its yesterday volume was recorded 31478994 in contrast with its average volume of 11,672,795.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
- What does Guardion Health Sciences (GHSI) Stock hold for Investors in 2021?
- 3 Best Marijuana Stocks to Watch for in 2021
In the after-market hours,the Stock price surged 32.73% to 0.73.What is the reason for today’s rise in this stock? There is still no straightforward answer to the question, except for ”over-excited investors.” The truth is that the only news that has specifically impacted stocks in the recent week is that Bret Scholtes, a veteran of the nutritional products industry for more than a decade, will be the company’s President and Chief Executive Officer and a member of the company’s Board of Directors, effective January 6, 2021.
Over the past nine years, Mr. Scholtes has been CEO of Omega Protein Corporation, a global nutritional products company that traded on the New York Stock Exchange. The company was successfully sold to a strategic buyer late last year. During his tenure at Omega, annualized revenues increased by 55%, EBITDA grew by more than 70%, and Omega’s stock price increased by approximately 260%.
Overall Market Condition is improving slightly since the announcement of Covid-19 vaccines. However, in this case, Investors optimism is more down to Mr. Bret Scholtes’ hiring, as they are hoping that he will repeat his past success stories in his new venture at Guardion Health Sciences, (GHSI).